Searchable abstracts of presentations at key conferences in endocrinology

ea0021p236 | Neuroendocrinology and behaviour | SFEBES2009

The endocrine and behavioural effects of high fat feeding

McNeilly Alison , Balfour David , Stewart Caroline

Diet induced obesity is associated with an increased relative risk of developing type 2 diabetes, hypertension, dyslipidemia and cardiovascular complications. In addition to these co-morbidity factors there is increasing evidence to suggest that obese insulin resistant individuals show impaired negative feedback control of the HPA axis in response to stress. Here we investigate HPA axis response to an acute stress following high fat feeding in rats.Male ...

ea0038oc4.1 | Diabetes and cardiometabolic complications | SFEBES2015

Acute intense exercise restores defective counter-regulation in type 1 diabetes through a process of dis-habituation

McNeilly Alison , Gallagher Jennifer , Wright Kathryn , McCrimmon Rory

Hypoglycaemia is an almost unavoidable consequence of iatrogenic insulin therapy in type 1 diabetes. Recurrent hypoglycaemia (RH) results in suppression of normal counter-regulatory hormonal and physiological responses (CRR) to future episodes increasing the risk of severe hypoglycaemia. The mechanisms responsible for this phenomenon remain unclear but may reflect changes in critical hypothalamic glucose sensing neurons (GSN). We set out to indirectly test the hypothesis that ...

ea0025p112 | Cytokines, growth factors, neuroendocrinology and behaviour | SFEBES2011

Characterisation of the stress--response in BACE1 heterozygous mice

Meakin Paul , Winter Johnathan , Ashford Mike , McNeilly Alison

Alzheimer’s disease (AD) is one of the most common causes of dementia world wide. Accumulation of β-amyloid (Aβ) has been implicated as a causal factor of AD. Beta secretase (BACE1) catalyses the rate limiting step in the production Aβ and has been postulated as a potential therapeutic target for AD treatment. Environmental factors, including psychological stress, accelerate the development of dementia and AD. This study examined hypothalamic–pituitary...

ea0038fp1 | (1) | SFEBES2015

Inhibition of NFAT signalling in vivo improves microvascular endothelial function in a mouse model of chronic diabetes

McNeilly Alison , Garcia-Vaz Eliana , Gallagher Jennifer , McCrimmon Rory , Gomez Maria , Khan Faisel

Vascular disease is a major cause of morbidity and mortality in people who have diabetes. Hyperglycaemia is associated with increased transcriptional activity of nuclear factor of activated T cells (NFAT) in the vasculature. NFAT activation enhances expression of pro-inflammatory mediators including osteopontin, COX2 and IL6, implicated in the development of vascular disease. This study investigated the therapeutic potential of NFAT inhibition on the progression of microvascul...

ea0038p192 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Central IL6 signalling and the development of impaired insulin secretion in type2 diabetes

Yiannakas Adonis , McNeilly Alison D , Gallagher Jennifer , Wright Kathryn , McCrimmmon Rory J

Obesity and the metabolic syndrome are chronic inflammatory states that are now understood to be involved in the development type 2 Diabetes. Hypothalamic cytokine signalling is thought to influence neuroendocrine networks critical to the dynamic maintenance of glucose homeostasis. Interleukin 6 (IL6) is a cytokine that displays tissue-specificity and is instrumental in the mounting of the acute phase response, as well as in the subsequent resolving and adaptive phase. IL6 is ...